Autologous And Allogeneic Cell Therapies: Benefits, Challenges, And Future Prospects

Cell and gene therapies (CGT) are at the frontline of clinical research and offer the potential to transform treatment for serious medical conditions. There are two types of cell therapies in development – autologous and allogeneic. Each provides distinct clinical and production advantages and challenges, and therapeutic capabilities. In this blog, we explore both autologous and allogeneic approaches, the solutions needed to optimize the development processes for commercial viability, and the future landscape of cell therapies in the rare disease space.